Improving Physical Properties via C-H Oxidation: Chemical and Enzymatic Approaches

Angewandte Chemie - International Edition

Volumn 53, Issue 45, 2014, Pages 12091-12096

  Michaudel, Quentin ^a   Journot, Guillaume ^a   Regueiro Ren, Alicia ^b   Goswami, Animesh ^b   Guo, Zhiwei ^b   Tully, Thomas P ^b   Zou, Lufeng ^c   Ramabhadran, Raghunath O ^c   Houk, Kendall N ^c   Baran, Phil S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C H activation; medicinal chemistry; oxidation; radical reactions; terpenoids

Indexed keywords

ACTIVATION ANALYSIS; MOLECULES; MUSCULOSKELETAL SYSTEM; REACTION KINETICS; SOLUBILITY;

C-H ACTIVATION; ENZYMATIC OXIDATIONS; MEDICINAL CHEMISTRY; PHYSICOCHEMICAL PROPERTY; RADICAL REACTIONS; SOLUBILITY ENHANCEMENT; SOLUBILITY MEASUREMENT; TERPENOIDS;

OXIDATION;

BIOLOGICAL PRODUCT; CARBON; HYDROGEN;

CHEMISTRY; OXIDATION REDUCTION REACTION; SOLUBILITY;

BIOLOGICAL PRODUCTS; CARBON; HYDROGEN; OXIDATION-REDUCTION; SOLUBILITY;

EID: 84911488613     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201407016     Document Type: Article

References (63)

1. I. Kola, J. Landis, Nat. Rev. Drug Discovery 2004, 3, 711;
2. M. Hay, D. W. Thomas, J. L. Craighead, C. Economides, J. Rosentha, Nat. Biotechnol. 2014, 32, 40.
3. S. M. Paul, D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, A. L. Schacht, Nat. Rev. Drug Discovery 2010, 9, 203.
4. N. A. Meanwell, Chem. Res. Toxicol. 2011, 24, 1420.
5. K. Chen, P. S. Baran, Nature 2009, 459, 824;
6. Y. Ishihara, P. S. Baran, Synlett 2010, 1733;
7. H. Renata, Q. Zhou, P. S. Baran, Science 2013, 339, 59;
8. L. Jørgensen, S. J. McKerrall, C. A. Kuttruff, F. Ungeheuer, J. Felding, P. S. Baran, Science 2013, 341, 878.
9. J. Genovino, S. Lütz, D. Sames, B. B. Touré, J. Am. Chem. Soc. 2013, 135, 12346. For a purely chemical approach to both predict and block metabolic hot spots using C-H functionalization, see:
10. F. O'Hara, A. C. Burns, M. R. Collins, D. Dalvie, M. A. Ornelas, A. D. N. Vaz, Y. Fujiwara, P. S. Baran, J. Med. Chem. 2014, 57, 1616.
11. J. T. Löwitz, Crell's Chem. Ann. 1788, 1, 312;
12. V. Bruckner, J. Kovacs, I. Koczka, J. Chem. Soc. Abstr. 1948, 948;
13. E. W. H. Hayek, U. Jordis, W. Moche, F. Sauter, Phytochemistry 1989, 28, 2229.
14. R. H. Cichewicz, S. A. Kouzi, Med. Res. Rev. 2003, 24, 90;
15. S. Alakurtti, T. Mäkelä, S. Koskimies, J. Yli-Kauhaluoma, Eur. J. Pharm. Sci. 2006, 29, 1.
16. L. Ruzicka, A. H. Lamberton, E. W. Christie, Helv. Chim. Acta 1938, 21, 1706;
17. A. Robertson, G. Soliman, E. C. Owen, J. Chem. Soc. 1939, 1267;
18. D. S. H. L. Kim, Z. Chen, V. T. Nguyen, J. M. Pezzuto, S. Qiu, Z. Lu, Synth. Commun. 1997, 27, 1607.
19. E. Pisha, H. Chai, I. S. Lee, T. E. Chagwedera, N. R. Farnsworth, G. A. Cordell, C. W. W. Beecher, H. H. S. Fong, A. D. Kinghorn, D. M. Brown, M. C. Wani, M. E. Wall, T. J. Hieken, T. K. Das Gupta, J. M. Pezzuto, Nat. Med. 1995, 1, 1046;
20. E. De Clercq, Med. Res. Rev. 2000, 20, 323.
21. Y. Deng, J. K. Snyder, J. Org. Chem. 2002, 67, 2864;
22. R. Mukherjee, M. Jaggi, M. J. A. Siddiqui, S. K. Srivastava, P. Rajendran, A. Vardhan, A. C. Burman, Bioorg. Med. Chem. Lett. 2004, 14, 4087;
23. R. C. Santos, J. A. R. Salvador, S. Marín, M. Cascante, Bioorg. Med. Chem. 2009, 17, 6241.
24. E. Suokas, T. Hase, Acta Chem. Scand. Ser. B 1975, 29, 139;
25. E. Suokas, T. Hase, Acta Chem. Scand. Ser. B 1977, 31, 182;
26. G. Dutta, S. N. Bose, Tetrahedron Lett. 1988, 29, 5807;
27. I. C. Sun, H. K. Wang, Y. Kashiwada, J. K. Shen, L. M. Cosentino, C. H. Chen, L. M. Yang, K. H. Lee, J. Med. Chem. 1998, 41, 4648;
28. J. Šarek, J. Klinot, P. Džubák, E. Klinotová, V. Nosková, V. Křeček, G. Kořínková, J. O. Thomson, A. Janošt'áková, S. Wang, S. Parsons, P. M. Fischer, N. Z. Zhelev, M. Hajdúch, J. Med. Chem. 2003, 46, 5402;
29. S. Alakurtti, T. Heiska, A. Kiriazis, N. Sacerdoti-Sierra, C. L. Jaffe, J. Yli-Kauhaluoma, Bioorg. Med. Chem. 2010, 18, 1573.
30. J. M. Allison, W. Lawie, J. McLean, G. R. Taylor, J. Chem. Soc. 1961, 3353;
31. A. Vystrčil, J. Protiva, Collect. Czech. Chem. Commun. 1974, 39, 1382;
32. S. K. Nag, S. N. Bose, Tetrahedron Lett. 1989, 30, 2855.
33. J. Sejbal, J. Klinot, M. Buděšínský, J. Protiva, Collect. Czech. Chem. Commun. 1991, 56, 2936;
34. J. Sejbal, J. Klinot, M. Buděšínský, J. Protiva, Collect. Czech. Chem. Commun. 1997, 62, 1905. Oxidation of C19 using dry ozonation or peracids in ca. 10 % yield have been disclosed as well:
35. E. Suokas, T. Hase, Acta Chem. Scand. Ser. B 1978, 32, 623;
36. M. Tori, R. Matsuda, Y. Asakawa, Chem. Lett. 1985, 167;
37. J. Sejbal, J. Klinot, A. Vystrčil, Collect. Czech. Chem. Commun. 1987, 52, 487.
38. T. Brückl, R. D. Baxter, Y. Ishihara, P. S. Baran, Acc. Chem. Res. 2012, 45, 826.
39. J. Waser, B. Gaspar, H. Nambu, E. M. Carreira, J. Am. Chem. Soc. 2006, 128, 11693.
40. For the first demonstration that 13C shifts could be used to assist in the prediction of C-H oxidation, see Ref. [4a]. See also:, M. A. Bigi, P. Liu, L. Zou, K. N. Houk, M. C. White, Synlett 2012, 2768.
41. L. Zou, R. S. Paton, A. Eschenmoser, T. R. Newhouse, P. S. Baran, K. N. Houk, J. Org. Chem. 2013, 78, 4037.
42. K. Chen, A. Eschenmoser, P. S. Baran, Angew. Chem. Int. Ed. 2009, 48, 9705;
43. Angew. Chem. 2009, 121, 9885.
44. J. S. Pyrek, Pol. J. Chem. 1979, 53, 2465.
45. E. M. Simmons, J. F. Hartwig, Nature 2012, 483, 70;
46. B. Li, M. Driess, J. F. Hartwig, J. Am. Chem. Soc. 2014, 136, 6586.
47. F. Sun, P. Zhu, H. Yao, X. Wu, J. Xu, J. Chem. Res. 2012, 254.
48. J. I. Concepciõn, C. G. Francisco, R. Hernández, J. A. Salazar, E. Suárez, Tetrahedron Lett. 1984, 25, 1953;
49. B. M. Trost, H. C. Shen, J.-P. Surivet, J. Am. Chem. Soc. 2004, 126, 12565.
50. V. Pouzar, J. Protiva, E. Lisá, E. Klinotová, A. Vystrčil, Collect. Czech. Chem. Commun. 1975, 40, 3046.
51. D. H. R. Barton, J. M. Beaton, J. Am. Chem. Soc. 1960, 82, 2640;
52. D. H. R. Barton, J. M. Beaton, L. E. Geller, M. M. Pechet, J. Am. Chem. Soc. 1961, 83, 4076.
53. H. Kropf, H. von Wallis, Synthesis 1981, 237;
54. H. Kropf, H. von Wallis, Synthesis 1983, 633;
55. H. Kropf, H. von Wallis, Liebigs Ann. Chem. 1983, 610;
56. H. Kropf, H. von Wallis, L. Bartnick, Liebigs Ann. Chem. 1983, 624;
57. Ž. Čekovic, M. M. Green, J. Am. Chem. Soc. 1974, 96, 3000;
58. Ž. Čekovic, Lj. Dimitrijevic, G. Djokic, T. Srnic, Tetrahedron 1979, 35, 2021.
59. J. Kalvoda, K. Heusler, Synthesis 1971, 601.
60. S. Lee, P. L. Fuchs, J. Am. Chem. Soc. 2002, 124, 13978;
61. E. McNeill, J. Du Bois, J. Am. Chem. Soc. 2010, 132, 10202;
62. J. Graeupner, T. P. Brewster, J. D. Blakemore, N. D. Schley, J. M. Thomsen, G. W. Brudvig, N. Hazari, R. H. Crabtree, Organometallics 2012, 31, 7158.
63. For the use of physiologically relevant media like FeSSIF or FaSSIF for solubility measurements of drug-like substrates, see:, J. H. Fagerberg, O. Tsinman, N. Sun, K. Tsinman, A. Avdeef, C. A. S. Bergström, Mol. Pharm. 2010, 7, 1419.